Usefulness of postoperative surveillance MR for women after breast-conservation therapy: Focusing on MR features of early and late recurrent breast cancer

被引:9
|
作者
Lee, Jeongmin [1 ]
Kang, Bong Joo [1 ]
Kim, Sung Hun [1 ]
机构
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea
来源
PLOS ONE | 2021年 / 16卷 / 06期
关键词
CONSERVING THERAPY; LOCAL RECURRENCE; FOLLOW-UP; SURVIVAL; RADIOTHERAPY; MAMMOGRAPHY; SURGERY; SOCIETY;
D O I
10.1371/journal.pone.0252476
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose To investigate the imaging characteristics of early and late recurrent breast cancer and the detectability of mammography, ultrasonography, and breast magnetic resonance imaging (MRI) in patients who underwent breast-conservation therapy (BCT). Materials and methods Total of 1312 women with 2026 surveillance breast MRI after BCT between January 2014 and September 2018 were studied. Early recurrence was defined as newly diagnosed breast cancer and/or axillary metastasis within 12 months of surgery. Late recurrence was defined as recurrence after 12months of surgery. We assessed the detectability of recurrent lesions in each postoperative imaging modality and evaluated characteristics of recurrent lesions on postoperative MRI by comparing early and late recurrence groups. Result Of the 2026 cases, 103 were confirmed as recurrent breast cancer by biopsy or surgery. Thirty-one cases were early recurrence, and 72 cases were late recurrence. MRI showed significantly higher detectability for recurrent lesions (102 cases, 99%) than mammography (59.4%, p < 0.001) or ultrasound (68.9%, p < 0.001), or both mammography and ultrasound (81.6%, p < 0.001). The recurrent lesions did not have typical malignant morphologic features, but variable features on MRI. However, early recurrent lesions showed fast enhancement in early dynamic phase regardless of the kinetic pattern of delayed dynamic phase; and late recurrence lesions showed early fast enhancement and delayed washout pattern. There were 19 cases which were not detected on mammography or ultrasound but could only be detected with MRI. Conclusion Postoperative breast MRI showed significantly higher detectability for recurrent lesions than mammography and ultrasound. Early fast enhancement is the most important feature of recurrent lesions on postoperative breast MRI for both early and late recurrence groups. Due to its high possibility of recurrence, further work-up should be considered regardless of their morphologic features.
引用
收藏
页数:17
相关论文
共 43 条
  • [41] Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial
    Meattini, Icro
    De Santis, Maria Carmen
    Visani, Luca
    Scorsetti, Marta
    Fozza, Alessandra
    Meduri, Bruno
    De Rose, Fiorenza
    Bonzano, Elisabetta
    Prisco, Agnese
    Masiello, Valeria
    La Rocca, Eliana
    Spoto, Ruggero
    Becherini, Carlotta
    Blandino, Gladys
    Moscetti, Luca
    Ray Colciago, Riccardo
    Audisio, Riccardo A.
    Brain, Etienne
    Caini, Saverio
    Hamaker, Marije
    Kaidar-Person, Orit
    Lambertini, Matteo
    Marrazzo, Livia
    Saieva, Calogero
    Spanic, Tanja
    Vratislav, Strnad
    Wheelwright, Sally
    Poortmans, Philip M. P.
    Livi, Lorenzo
    EUROPA Trial Investigators
    LANCET ONCOLOGY, 2025, 26 (01) : 37 - 50
  • [42] Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
    Olaf Johan Hartmann-Johnsen
    Rolf Kåresen
    Ellen Schlichting
    Jan F. Nygård
    World Journal of Surgical Oncology, 15
  • [43] Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
    Smith, Ian
    Robertson, John
    Kilburn, Lucy
    Wilcox, Maggie
    Evans, Abigail
    Holcombe, Chris
    Horgan, Kieran
    Kirwan, Cliona
    Mallon, Elizabeth
    Sibbering, Mark
    Skene, Anthony
    Vidya, Raghavan
    Cheang, Maggie
    Banerji, Jane
    Morden, James
    Sidhu, Kally
    Dodson, Andrew
    Bliss, Judith M.
    Dowsett, Mitch
    LANCET ONCOLOGY, 2020, 21 (11) : 1443 - 1454